Table 8.
Summary of studies on oral microbiota in children with autism
Ref.
|
Population
|
Intervention
|
Comparison
|
Outcome
|
Study design
|
Key findings
|
Study quality rating
|
Kong et al[70], 2019 | Children with ASD and neurotypical controls | Analysis of oral and gut microbiota using 16S rRNA sequencing | Neurotypical children | Identified distinct oral and gut microbiota signatures; explored microbial biomarkers for ASD diagnosis | Pilot study | ASD children had unique oral microbiota profiles with potential diagnostic biomarkers; suggested probiotics could alter microbiome and improve comorbid conditions | Moderate quality |
Evenepoel et al[71], 2024 | 80 autistic children (8-12 years) and 40 neurotypical peers | Examination of oral microbiota differences using high-throughput sequencing | Typically developing children | ASD children had higher abundances of Solobacterium, Stomatobaculum, Ruminococcaceae UCG.014, Tannerella, and Campylobacter; associations found with social difficulties and anxiety | Cross-sectional study | Oral microbiome variations correlated with ASD symptom severity and were not significantly driven by lifestyle factors | High quality |
Qiao et al[72], 2018 | 32 ASD children and 27 healthy controls | High-throughput sequencing of salivary and dental microbiota | Neurotypical children | ASD children had lower bacterial diversity, higher pathogenic bacteria (Haemophilus, Streptococcus), and reduced commensals (Prevotella, Fusobacterium, Actinomyces) | Case-control study | Significant microbiota differences in ASD children; proposed microbial markers for ASD diagnosis | Moderate |
ASD: Autism spectrum disorder; rRNA: Ribosomal ribonucleic acid.